Awareness of J&J lawsuits affects the company stocks
Awareness of J&J lawsuits affects the company stocks
Introduction
As J&J is vigorously defending itself in the second ongoing mesothelioma trial allegedly linked to its Talcum Powder product, the company witnessed a dip in its stock value by 5 % earlier this month attributed to the unveiling of documents at the court that revealed the talc powder contained asbestos and other cancer-causing heavy metals.
The giant conglomerate is also facing thousands of ovarian cancer lawsuits filed on behalf of women who allegedly developed ovarian cancer linked to the use of Talcum Powder for feminine hygiene purposes.
Comments
Latest News
Talcum Powder Cancer Settlement Talks Begin Sept. 4
Categories: Talcum
Representatives of Johnson & Johnson (J&J) and attorneys for tens of thousands of plaintiffs involved in talcum powder lawsuits are scheduled to meet in September 2025 in an…
Tepezza Hearing Loss Trials Delayed Until Aug 2026
Categories: Tepezza
A series of Tepezza hearing loss lawsuits, which were expected to go before juries next year, will now be delayed. The U.S. District Judge overseeing the multidistrict…
Cencora Directors Settle Opioid Oversight Case for $111M
Categories: Opioids
Cencora has agreed to pay $111.3 million to settle a shareholder lawsuit accusing the company’s directors of failing to prevent the unlawful distribution of opioids…